微創(chuàng)小切口零切跡頸前路椎間融合器治療單節(jié)段脊髓型頸椎病的臨床價(jià)值分析

　　【摘要】 目的 探究微創(chuàng)小切口零切跡頸前路椎間融合器治療單節(jié)段脊髓型頸椎病的臨床價(jià)值。方法 80例單節(jié)段脊髓型頸椎病患者作為研究對(duì)象， 均采用微創(chuàng)小切口零切跡頸前路椎間融合器治療， 觀察手術(shù)效果， 對(duì)比手術(shù)前后的視覺(jué)模擬評(píng)分法（VAS）評(píng)分、日本骨科協(xié)會(huì)（JOA）評(píng)分、椎間隙高度以及Cobb角變化。結(jié)果 患者手術(shù)平均時(shí)長(zhǎng)（53.26±10.21）min， 平均術(shù)中出血量（35.14±10.32）ml， 平均住院時(shí)間（5.6±1.6）d;術(shù)后并發(fā)生癥總發(fā)生率為7.50%。術(shù)后1周、末次隨訪時(shí)的VAS、JOA評(píng)分與術(shù)前對(duì)比差異均具有統(tǒng)計(jì)學(xué)意義（P<0.05）;末次隨訪時(shí)的VAS、JOA評(píng)分與術(shù)后1周對(duì)比差異均具有統(tǒng)計(jì)學(xué)意義（P<0.05）。術(shù)后1周、末次隨訪時(shí)的椎間隙高度、Cobb角與術(shù)前對(duì)比差異均具有統(tǒng)計(jì)學(xué)意義（P<0.05）;末次隨訪時(shí)的椎間隙高度、Cobb角與術(shù)后1周對(duì)比差異均無(wú)統(tǒng)計(jì)學(xué)意義（P>0.05）。結(jié)論 微創(chuàng)小切口零切跡頸前路椎間融合器治療單節(jié)段脊髓型頸椎病療效顯著， 具有推廣價(jià)值。
　　【關(guān)鍵詞】 微創(chuàng);小切口;零切跡頸前路椎間融合器;單節(jié)段;脊髓型頸椎病
　　DOI：10.14163/j.cnki.11-5547/r.2018.12.011
　　【Abstract】 Objective To investigate the clinical value of minimally invasive small incision and zero-incisura cervical anterior interbody fusion for the treatment of single-segment cervical spondylotic myelopathy. Methods A total of 80 patients with single-segment cervical spondylotic myelopathy as study subjects were all treated with minimally invasive small incision and zero-incisura cervical anterior interbody fusion， and their surgical effect was observed. Comparison were made on visual analogue scale （VAS）， Japanese Orthopedic Association （JOA） score， intervertebral height and Cobb angle changes between the two groups. Results Patients had average operation time as （53.26±10.21） min， average intraoperative bleeding volume as （35.14±10.32） ml，
　　mean hospitalization time as （5.6±1.6） d， and incidence of total postoperative complications as 7.50%. There was statistically significant difference in VAS and JOA score in postoperative 1 week and last follow-up， comparing with before operation （P<0.05）. There was statistically significant difference in VAS and JOA score at last follow-up， comparing with postoperative 1 week （P<0.05）. There was statistically significant difference in intervertebral height and Cobb angle in postoperative 1 week and last follow-up， comparing with before operation （P<0.05）. There was no statistically significant difference in intervertebral height and Cobb angle at last follow-up， comparing with postoperative 1 week （P>0.05）. Conclusion Minimally invasive small incision and zero-incisura cervical anterior interbody fusion shows remarkable efficacy for the treatment of single-segment cervical spondylotic myelopathy， and it contains promotion value.
　　【Key words】 Minimally invasive; Small incision; Zero-incisura cervical anterior interbody fusion; Single-segment; Cervical spondylotic myelopathy
　　目前， 脊柱外科已經(jīng)得以迅速發(fā)展， 微創(chuàng)融合術(shù)已經(jīng)廣泛應(yīng)用到臨床治療中， 廣受單節(jié)段脊髓型頸椎病的歡迎。微創(chuàng)小切口零切跡頸前路椎間融合器治療法巧妙地應(yīng)用力學(xué)穩(wěn)定性， 將融合器打入患者的椎體中， 達(dá)到了有效支撐、固定椎體的作用[1]。本研究對(duì)本院2013年5月～2016年10月收治的80例單節(jié)段脊髓型頸椎病患者進(jìn)行分析， 旨在探究微創(chuàng)小切口零切跡頸前路椎間融合器治療的應(yīng)用價(jià)值。現(xiàn)報(bào)告如下。

相關(guān)熱詞搜索：脊髓 前路 頸椎病 臨床 融合